FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1826626970> ?p ?o ?g. }

• W1826626970 endingPage "e0141425" @default.
• W1826626970 startingPage "e0141425" @default.
• W1826626970 abstract "Background Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied. Methods We randomly assigned 68 incident PD patients to low GDP (Intervention Group) or conventional solutions (Control Group); 4 dropped off before they received the assigned treatment. Patients were followed for 52 weeks for changes in ultrafiltration, residual renal function, body fluid status and arterial PWV. Result After 52 weeks, Intervention Group had higher overhydration (3.1 ± 2.6 vs 1.9 ± 2.2 L, p = 0.045) and extracellular water volume (17.7 ± 3.9 vs 15.8 ± 3.1 L, p = 0.034) than Control Group. There was no significant difference in PWV between groups. There was no significant difference in residual renal function between the Groups. Intervention Group had lower ultrafiltration volume than Control Group at 4 weeks (0.45 ± .0.61 vs 0.90 ± 0.79 L/day, p = 0.013), but the difference became insignificant at later time points. Intervention Group had lower serum CRP levels than Control Group (4.17 ± 0.77 vs 4.91 ± 0.95 mg/dL, p < 0.0001). Conclusion Incident PD patients treated with low GDP solution have less severe systemic inflammation but trends of less ultrafiltration, and more fluid accumulation. However, the effects on ultrafiltration and fluid accumulation disappear with time. The long term effect of low GDP solution requires further study. Trial Registration ClinicalTrials.gov NCT00966615" @default.
• W1826626970 created "2016-06-24" @default.
• W1826626970 creator A5000398237 @default.
• W1826626970 creator A5000706991 @default.
• W1826626970 creator A5006663907 @default.
• W1826626970 creator A5011472256 @default.
• W1826626970 creator A5053550425 @default.
• W1826626970 creator A5057029922 @default.
• W1826626970 creator A5063429550 @default.
• W1826626970 creator A5070401295 @default.
• W1826626970 creator A5091345161 @default.
• W1826626970 date "2015-10-28" @default.
• W1826626970 modified "2023-10-10" @default.
• W1826626970 title "The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition – A Randomized Control Trial" @default.
• W1826626970 cites W1899442605 @default.
• W1826626970 cites W1902719690 @default.
• W1826626970 cites W1971221852 @default.
• W1826626970 cites W1984368679 @default.
• W1826626970 cites W1988520676 @default.
• W1826626970 cites W2004661312 @default.
• W1826626970 cites W2022288576 @default.
• W1826626970 cites W2044626889 @default.
• W1826626970 cites W2048555639 @default.
• W1826626970 cites W2051865146 @default.
• W1826626970 cites W2055875650 @default.
• W1826626970 cites W2069504946 @default.
• W1826626970 cites W2072124048 @default.
• W1826626970 cites W2078529684 @default.
• W1826626970 cites W2084318392 @default.
• W1826626970 cites W2097335942 @default.
• W1826626970 cites W2098854885 @default.
• W1826626970 cites W2103705498 @default.
• W1826626970 cites W2105710882 @default.
• W1826626970 cites W2117641467 @default.
• W1826626970 cites W2143090372 @default.
• W1826626970 cites W2144601461 @default.
• W1826626970 cites W2151272377 @default.
• W1826626970 cites W2153281701 @default.
• W1826626970 cites W2156994754 @default.
• W1826626970 cites W2158123809 @default.
• W1826626970 cites W2159200241 @default.
• W1826626970 cites W2167969296 @default.
• W1826626970 cites W2169169045 @default.
• W1826626970 cites W2181319562 @default.
• W1826626970 cites W2189015859 @default.
• W1826626970 cites W2346692818 @default.
• W1826626970 cites W2410316532 @default.
• W1826626970 cites W4241142722 @default.
• W1826626970 doi "https://doi.org/10.1371/journal.pone.0141425" @default.
• W1826626970 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4625015" @default.
• W1826626970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26510186" @default.
• W1826626970 hasPublicationYear "2015" @default.
• W1826626970 type Work @default.
• W1826626970 sameAs 1826626970 @default.
• W1826626970 citedByCount "16" @default.
• W1826626970 countsByYear W18266269702016 @default.
• W1826626970 countsByYear W18266269702017 @default.
• W1826626970 countsByYear W18266269702018 @default.
• W1826626970 countsByYear W18266269702019 @default.
• W1826626970 countsByYear W18266269702021 @default.
• W1826626970 countsByYear W18266269702022 @default.
• W1826626970 countsByYear W18266269702023 @default.
• W1826626970 crossrefType "journal-article" @default.
• W1826626970 hasAuthorship W1826626970A5000398237 @default.
• W1826626970 hasAuthorship W1826626970A5000706991 @default.
• W1826626970 hasAuthorship W1826626970A5006663907 @default.
• W1826626970 hasAuthorship W1826626970A5011472256 @default.
• W1826626970 hasAuthorship W1826626970A5053550425 @default.
• W1826626970 hasAuthorship W1826626970A5057029922 @default.
• W1826626970 hasAuthorship W1826626970A5063429550 @default.
• W1826626970 hasAuthorship W1826626970A5070401295 @default.
• W1826626970 hasAuthorship W1826626970A5091345161 @default.
• W1826626970 hasBestOaLocation W18266269701 @default.
• W1826626970 hasConcept C126322002 @default.
• W1826626970 hasConcept C126894567 @default.
• W1826626970 hasConcept C134018914 @default.
• W1826626970 hasConcept C159641895 @default.
• W1826626970 hasConcept C168563851 @default.
• W1826626970 hasConcept C185592680 @default.
• W1826626970 hasConcept C2113261 @default.
• W1826626970 hasConcept C2776735168 @default.
• W1826626970 hasConcept C2778063415 @default.
• W1826626970 hasConcept C2778319312 @default.
• W1826626970 hasConcept C2779056158 @default.
• W1826626970 hasConcept C28406088 @default.
• W1826626970 hasConcept C43617362 @default.
• W1826626970 hasConcept C50817676 @default.
• W1826626970 hasConcept C55493867 @default.
• W1826626970 hasConcept C71924100 @default.
• W1826626970 hasConcept C84393581 @default.
• W1826626970 hasConcept C90924648 @default.
• W1826626970 hasConceptScore W1826626970C126322002 @default.
• W1826626970 hasConceptScore W1826626970C126894567 @default.
• W1826626970 hasConceptScore W1826626970C134018914 @default.
• W1826626970 hasConceptScore W1826626970C159641895 @default.
• W1826626970 hasConceptScore W1826626970C168563851 @default.
• W1826626970 hasConceptScore W1826626970C185592680 @default.
• W1826626970 hasConceptScore W1826626970C2113261 @default.

• next